Mastodon

Benzylbenzoate (Ointment, Emulsion) Instructions for Use

ATC Code

P03AX01 (Benzyl benzoate)

Active Substance

Benzyl benzoate (Ph.Eur. European Pharmacopoeia)

Clinical-Pharmacological Group

Scabies treatment drug

Pharmacotherapeutic Group

Antiscabietic agent

Pharmacological Action

Antiparasitic drug for external use. It is active against scabies mites and lice.

Indications

  • Treatment of scabies.

ICD codes

ICD-10 code Indication
B86 Scabies
ICD-11 code Indication
1G04 Scabies

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Ointment

The course of treatment lasts 4 days.

Adults are prescribed a 20% ointment, and children are prescribed a 10% ointment.

On the first day, the treatment is performed in the evening before bedtime after thorough washing in the shower with warm water and soap. The ointment is rubbed into the skin of the hands, then the torso and legs, including the soles and toes. After skin treatment, only clean underwear and clothes should be used.

On the 2nd and 3rd days, a break in treatment is taken, and the residue of the ointment is not washed off the skin. On the 4th day in the evening, the patient washes with soap and rubs in the ointment as on the first day, using the remaining ointment and changing all underwear again.

Hands should not be washed for 3 hours after treatment; subsequently, hands are treated with the ointment after each washing.

If the emulsion is washed off from other areas of the skin, they must also be re-treated. The ointment is completely washed off the skin on the fifth day of treatment.

Treatment of complicated scabies (dermatitis, eczema, pyoderma, post-scabious lymphoplasia) should be carried out simultaneously with the treatment of scabies and continue after its completion.

Emulsion

For external use. The dosage regimen depends on the indications and the dosage form used.

Adverse Reactions

Local reactions possibly (especially in children) a burning sensation, skin irritation.

Contraindications

  • Not recommended for children under 3 years of age;
  • Pregnancy;
  • Breastfeeding period.

Use in Pregnancy and Lactation

Not recommended for use during pregnancy and breastfeeding.

Pediatric Use

Not recommended for children under 3 years of age.

Special Precautions

Treatment of patients identified in the same focus, as well as contact persons, should be carried out simultaneously to avoid re-infection.

Persistence of itching after treatment is not an indication for prescribing an additional course of specific therapy. Itching is the body’s reaction to the killed mite and its waste products and disappears with the appointment of antihistamines and corticosteroid ointments.

After treatment, medical supervision is necessary for 2 weeks, and in the presence of complications, for a longer period.

Avoid getting the drug on the mucous membranes, as severe burning occurs. Small children should wear a shirt with sewn-up sleeves after treatment.

All linen and other items that have been in contact with infected skin must be thoroughly processed. Bedding, towels, and bed linen are boiled in a washing powder solution for 5-10 minutes.

Outer clothing is ironed on both sides with a hot iron.

Items not subject to heat treatment are hung outdoors for 3 days.

Shoes, toys, and other items are excluded from use for 5 days and placed in a plastic bag.

Mattresses, pillows, and blankets are also excluded from use for 5 days or subjected to chamber disinfection.

Upholstered furniture can be treated with insecticides.

It is necessary to clean the apartment, wash the floors with detergents or with the addition of disinfectants.

Avoid getting the drug in the eyes, nose, or mouth.

If the drug gets into the mouth: rinse thoroughly with water or a 2% solution of warm drinking soda and ensure rest.

If the drug enters the stomach: the stomach is washed with a 1-2% solution of drinking soda, an aqueous mixture of burnt magnesia and activated charcoal, or an aqueous mixture of crushed chalk (2 tablespoons per 1 liter of water), after which a mixture of 1-2 tablespoons of activated charcoal and burnt magnesia in a glass of water is given to drink, then a saline laxative is taken (do not give castor oil!).

If the drug gets into the eyes: rinse thoroughly with water or drinking soda; if the mucous membrane of the eyes is irritated, instill a 30% solution of sulfacetamide (albucid) behind the eyelid, for pain – a 2% solution of procaine (novocaine).

If signs of skin irritation appear, the use of the drug should be discontinued.

Storage Conditions

Store in a place inaccessible to children at a temperature not exceeding 20°C (68°F).

Shelf Life

The shelf life is 3 years. Do not use the drug after the expiration date.

Dispensing Status

The drug is dispensed without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Altayvitamins, JSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: tubes 25 g or 30 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Biosintez, PJSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 20%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Bryntsalov-A, JSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 10%: tubes 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Bryntsalov-A, JSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 20%: tubes 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Zelenaya Dubrava, CJSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: tubes 25 g, 30 g, or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use homogeneous, white or white with a yellowish tint, with a specific odor; the presence of air bubbles is allowed.

100 g
Benzyl benzoate 20 g

Excipients : sodium hydroxide – 0.2 g, methylparahydroxybenzoate – 0.08 g, propylparahydroxybenzoate – 0.02 g, carbomer – 2 g, polysorbate 80 – 1 g, purified water – up to 100 g.

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Lugansk Chemical And Pharmaceutical Plant, PJSC (Ukraine)

Dosage Form

Bottle Rx Icon Benzyl benzoate Topical emulsion 20%: 50 g or 100 g jars, 50 g or 100 g bottles

Dosage Form, Packaging, and Composition

Topical emulsion 20% 1 g
Benzyl benzoate 200 mg

50 g – dark glass bottles (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.

Marketing Authorization Holder

Moscow Pharmaceutical Factory CJS (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 10%: tubes 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Moscow Pharmaceutical Factory CJS (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: tubes 30 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

30 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Murom Instrument-Making Plant, FSUE (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 10%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Murom Instrument-Making Plant, FSUE (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Nizhpharm JSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use white or white with a yellowish tint, with a specific odor; the presence of air bubbles is allowed.

1 g
Benzyl benzoate 200 mg

Excipients : trolamine, stearic acid 95, macrogol 400, purified water.

25 g – aluminum tubes (1) – cardboard packs.
25 g – polyethylene laminated tubes (1) – cardboard packs.

Marketing Authorization Holder

Promomed Rus LLC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 10%: jars 25 g, 30 g, 40 g, or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – dark glass jars (1) – cardboard packs.
30 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
50 g – dark glass jars (1) – cardboard packs.

Marketing Authorization Holder

Promomed Rus LLC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: jars 25 g, 30 g, 40 g, or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – dark glass jars (1) – cardboard packs.
30 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
50 g – dark glass jars (1) – cardboard packs.

Marketing Authorization Holder

Retinoids JSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Topical emulsion 20%: 50 g or 100 g bottle, 200 g jar, 10 kg canisters

Dosage Form, Packaging, and Composition

Topical emulsion 20% 1 g
Benzyl benzoate 200 mg

50 g – bottles (1) – cardboard packs.
100 g – bottles (1) – cardboard packs.
200 g – jars (1) – cardboard packs.
10 kg – polyethylene canisters.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: 25 or 50 g jars, 25 or 30 g tubes

Dosage Form, Packaging, and Composition

Ointment for external use 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
50 g – dark glass jars (1) – cardboard packs.

Marketing Authorization Holder

Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: jars 15 g, 20 g, 25 g, or 30 g; tubes 25 g, 30 g, 40 g, 50 g, 70 g, 80 g, or 100 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% is homogeneous, white or white with a yellowish tint, with a specific odor; the presence of air bubbles is allowed.

100 g
Benzyl benzoate 20 g

Excipients: sodium hydroxide – 0.2 g, methylparaben (Nipagin) – 0.08 g, propylparaben (Nipasol) – 0.02 g, carbomer (Arespol, polyacrylate lightly crosslinked) – 2 g, polysorbate 80 (Tween 80) – 1 g, purified water – 76.7 g.

15 g – dark glass jars (1) – cardboard packs.
20 g – dark glass jars (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
30 g – dark glass jars (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
70 g – aluminum tubes (1) – cardboard packs.
80 g – aluminum tubes (1) – cardboard packs.
100 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Topical emulsion 20%: 50 g, 100 g, or 200 g bottle

Dosage Form, Packaging, and Composition

Topical emulsion is homogeneous, white or almost white, with a faint specific odor; sedimentation of emulsion particles is allowed, which disappears after shaking.

100 g
Benzyl benzoate 20 g

Excipients: solid laundry soap – 1 g, emulsifier No. 1 – 1 g, purified water – 78 g.

50 g – orange glass bottles (1) – cardboard packs.
100 g – orange glass bottles (1) – cardboard packs.
200 g – orange glass bottles (1) – cardboard packs.

Marketing Authorization Holder

Pharmaceutical Company Zdorovye, LLC (Ukraine)

Dosage Form

Bottle OTC Icon Benzyl benzoate Emulsion for external use 20%: bottle 50 g or 100 g

Dosage Form, Packaging, and Composition

Emulsion for external use 20% 1 g
Benzyl benzoate 200 mg

100 g – bottles (1) – cardboard packs.
50 g – bottles (1) – cardboard packs.

Marketing Authorization Holder

Pharmaceutical Factory Of St. Petersburg, PJSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 10%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Pharmaceutical Factory Of St. Petersburg, PJSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 20%: tube 25 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Pharmstandard-Fitopharm-NN LLC (Russia)

Manufactured By

Pharmstandard-Fitopharm-NN LLC (Russia)

Or

Pharmstandard JSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 10%: jars 25 g or 40 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.

Marketing Authorization Holder

Pharmstandard-Fitopharm-NN LLC (Russia)

Manufactured By

Pharmstandard-Fitopharm-NN LLC (Russia)

Or

Pharmstandard JSC (Russia)

Dosage Form

Bottle Rx Icon Benzyl benzoate Ointment for external use 20%: jars 25 g or 40 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate 200 mg

25 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.

Marketing Authorization Holder

Formula-FR, LLC (Russia)

Manufactured By

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Ointment for external use 20%: jars 25 g, tubes 25 g or 30 g

Dosage Form, Packaging, and Composition

Ointment for external use is from white to white with a yellowish tint, homogeneous, with a specific odor; the presence of air bubbles is allowed.

100 g
Benzyl benzoate 20 g

Excipients: trolamine (thermostable triethanolamine) – 5 g, stearic acid – 20 g, macrogol 400 (polyethylene oxide 400) – 5 g, purified water – up to 100 g.

25 g – dark glass jars (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Grindeks, JSC (Latvia)

Manufactured By

Grindeks, JSC (Latvia)

Or

Tallinn Pharmaceutical Company (Estonia)

Dosage Form

Bottle OTC Icon Benzyl benzoate Grindeks Ointment for external use 20%: tube 30 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate medical 200 mg

30 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Aspen Pharma, Pty. Ltd. (India)

Manufactured By

Waltham-Pharmacy, LLC (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate medicine unguentum Ointment for external use 10%: tubes 25 g, 30 g, or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Aspen Pharma, Pty. Ltd. (India)

Manufactured By

Waltham-Pharmacy, LLC (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate medicine unguentum Ointment for external use 20%: tubes 25 g, 30 g, or 50 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate medical 200 mg

25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Kirov Pharmaceutical Factory, SUE (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate unguentum Ointment for external use 20%: jars 25 g, 30 g, 40 g, 50 g or 75 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate medical 200 mg

25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
75 g – jars (1) – cardboard packs.

Marketing Authorization Holder

Lekko, CJS (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate unguentum Ointment for external use 10%: jars 25 g, 30 g, 40 g, 50 g or 75 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
75 g – jars (1) – cardboard packs.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate unguentum Ointment for external use 10%: jars 25 g, 30 g, 40 g, 50 g or 75 g

Dosage Form, Packaging, and Composition

Ointment for external use 10% 1 g
Benzyl benzoate 100 mg

25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
75 g – jars (1) – cardboard packs.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle Rx Icon Benzylbenzoate unguentum Ointment for external use 20%: jars 25 g, 30 g, 40 g, 50 g or 75 g

Dosage Form, Packaging, and Composition

Ointment for external use 20% 1 g
Benzyl benzoate medical 200 mg

25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
75 g – jars (1) – cardboard packs.

Table of Contents

TABLE OF CONTENTS